KR920012029A - 3위치에 치환된 인돌(indole)의 신규의 제조방법 및 본 방법에서 유용한 중간체 - Google Patents

3위치에 치환된 인돌(indole)의 신규의 제조방법 및 본 방법에서 유용한 중간체 Download PDF

Info

Publication number
KR920012029A
KR920012029A KR1019910022262A KR910022262A KR920012029A KR 920012029 A KR920012029 A KR 920012029A KR 1019910022262 A KR1019910022262 A KR 1019910022262A KR 910022262 A KR910022262 A KR 910022262A KR 920012029 A KR920012029 A KR 920012029A
Authority
KR
South Korea
Prior art keywords
reacting
group
compound
acetaldehyde
nitrophenyl
Prior art date
Application number
KR1019910022262A
Other languages
English (en)
Other versions
KR100228328B1 (ko
Inventor
톰스 쟈콥스 로버트
프란시스 코스텔로 제라드
아란 브룩 스테펜
존 하리슨 페터
Original Assignee
수잔 제인 젠틀
임페리얼 케미칼 인더스트리스 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 수잔 제인 젠틀, 임페리얼 케미칼 인더스트리스 피엘씨 filed Critical 수잔 제인 젠틀
Publication of KR920012029A publication Critical patent/KR920012029A/ko
Application granted granted Critical
Publication of KR100228328B1 publication Critical patent/KR100228328B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

3위치에 치환된 인돌(indole)의 신규의 제조방법 및 본 방법에서 유용한 중간체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. (a) N-(2-니트로스티릴)엔아민과 알킬화제를 반응시켜 이민염을 수득하는 단계, (b) 상기 이민염과 물을 임의로 반응시켜 (2-니트로페닐)아세트알데히드를 수득하는 단계, 및 (c)상 이민염 또는 (2-니트로페닐)아세트알데히드와 니트로기를 선택적으로 환원시킬 수 있는 환원제를 반응시켜 바람직한 3-알킬화된 인돌을 수득하는 단계를 포함하는 3-알킬화된 인돌의 제조방법.
  2. 제1항에 있어서, 상기 이민염과 물을 반응시켜 (2-니트로페닐)아세트알데히드를 수득하는 방법.
  3. 제1항 또는 제2항에 있어서, 상기 N-(2-니트로스티릴)엔아민이 2-니트로-β-(디-(1-4C)알킬아미노)스티렌, 2-니트로-β-(1-피롤리디닐)스티렌, 2-니트로-β-(1-피페리디닐)-스티렌 또는 2-니트로-β-(4-몰포리닐)스티렌인 것을 특징으로 하는 방법.
  4. 제1항 내지 제3항 중 어느 한항에 있어서, 상기 N-(2-니트로스티릴)엔아민은 하기 일반식(Ⅳ)의 화합물이고, 상기 알킬화제는 하기 일반식 화합물의 방법.
    (상기식에서 각각의 R은 (1-4C)알킬기이거나, 함께 4- 또는 5-원알킬렌이거나 헤테로알킬렌 사슬이고, X는 이탈원자 또는 이탈기이고, T는 COORh, U는 COORj이고, Rh와 Rj는 각각 따로 쉽게 제저할 수 있는 산보호기이다.)
  5. 제1항 내지 제4항 중 어느 한항에 있어서, 상기 환원제가 산의 존재시 철;스태너스 클로라이드;티타늄 트리클로라이드;소듐 니티오나이트;라니 니켈을 갖는 히드라진;또는 전이 금속 수소화 촉매의 존재시 수소인 것을 특징으로 하는 방법.
  6. 제5항에 있어서, 상기 환원제가 아세트산의 존재시 철인 것을 특징으로 하는 방법.
  7. 제1항 내지 제6항중 어느 한항에 있어서, 상기 알킬화 반응과 환원 반응이 0내지 120℃의 온도범위에서 효과적인 것을 특징으로하는 방법.
  8. 제1항 내지 제7항중 어느 한항에 있어서, 상기 이민염을 물과 0내지 100℃에서 반응시키는 방법.
  9. 하기 일반식 Ⅷ의 (2-니트로페닐)아세트알데히드;
    (상기식에서 T는 COORhU는 COORj, 그리고 Rh와 Rj는 각각 따로 페닐, 벤질, 및 아세톡시, (1-4C)알콕시 또는 (1-4C)알킬티오 치환체를 임의로 가지는 (1-6C)알킬중에서 선택된 용이하게 제거할 수 있는 산보호기이다)
  10. 4-[5-(N-[4,4,4-트리플루오르-2-메틸부틸]-카르바모일)-1-메틸인돌-3-일메틸]-3-메톡시-N-O-토릴설포닐-벤자미드의 제조시, 제9항의 (2-니트로페닐)아세트알데히드를 사용하는 방법.
  11. (a)하기 일반식(Ⅴ)의 화합물과 하기 일반식(Ⅳ)의 화합물을 반응시켜 이민염을 수득하는 단계, (b)상기 이민염과 물을 반응시켜 하기 일반식(Ⅷ)의 (2-니트로페닐)아세트알데히드를 수득하는 단계, (c)상기 (2-니트로페닐)아세트 알데히드와 니트로기를 선택적으로 환원시킬 수 있는 환원제를 반응시켜 하기 일반식(Ⅵ)의 화합물을 수득하는 단계, (d) 하기일반식(Ⅵ)의 화합물을 메틸화하여 일반식(Ⅶ)의 화합물을 수득하는 단계, (e)상기 기를 Rh보호기를 제거함으로써, 2-메틸벤젠설폰아al카르보닐기로 전환하고 생성된 카르복실산 또는 그것의 반응 유도체와 2-메틸벤젠설폰아미드 또는 그것의 염을 반응시키는 단계, 및 (f)상기 U기를 Rj보호기를 제거함으로써 2-메틸-4,4,4-트리플루오로 부틸아미노카르보닐기로 전환하고 생성된 카르복실산 또는 그것의 반응 유도체와 2-메틸-4,4,4-트리플루오로부틸아민 또는 그것의 산부가염을 반응시키는 단계를 포함하는 4-[5-(N-[4,4,4-트리플루오로-2-메틸부틸]-카르바모일)-1-메틸인돌-3-일메틸]-3-메톡시-N-O-토릴설포닐벤자미드 제조방법.
    (상기식에서 각각의 R은 따로 (1-4C)알킬이거나, 함께 4-또는 5-원 알킬렌 또는 헤테로알킬렌 사슬이고, X는 이탈원자 또는 이탈기, T는 COORh, U는 COORj, 그리고 Rh및 Rj는 각각 따로 용이하게 제거할 수 있는 산보호기이다.)
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910022262A 1990-12-05 1991-12-04 (2r)-메틸-4,4,4-트리플루오로부틸아민 또는 이것의 산부가염을 제조하는 방법 KR100228328B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9026427.6 1990-12-05
GB909026427A GB9026427D0 (en) 1990-12-05 1990-12-05 Chemical process
GB9026425.0 1990-12-05

Publications (2)

Publication Number Publication Date
KR920012029A true KR920012029A (ko) 1992-07-25
KR100228328B1 KR100228328B1 (ko) 1999-11-01

Family

ID=10686509

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910022262A KR100228328B1 (ko) 1990-12-05 1991-12-04 (2r)-메틸-4,4,4-트리플루오로부틸아민 또는 이것의 산부가염을 제조하는 방법

Country Status (22)

Country Link
US (1) US5280125A (ko)
EP (1) EP0489547B1 (ko)
JP (1) JP3160040B2 (ko)
KR (1) KR100228328B1 (ko)
AT (1) ATE168998T1 (ko)
AU (1) AU652002B2 (ko)
CA (1) CA2056065C (ko)
CZ (1) CZ282019B6 (ko)
DE (1) DE69129894T2 (ko)
DK (1) DK0489547T3 (ko)
ES (1) ES2118743T3 (ko)
FI (1) FI102170B1 (ko)
GB (1) GB9026427D0 (ko)
HU (1) HU222123B1 (ko)
IE (1) IE913936A1 (ko)
IL (1) IL100055A (ko)
NO (1) NO175680C (ko)
NZ (1) NZ240624A (ko)
PT (1) PT99683B (ko)
RU (1) RU2054417C1 (ko)
SK (1) SK278987B6 (ko)
ZA (1) ZA919079B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
CN112457235B (zh) * 2020-12-02 2023-04-25 烟台凯博医药科技有限公司 一种7-甲基吲哚的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976639A (en) * 1970-11-04 1976-08-24 Hoffmann-La Roche Inc. Intermediates for indoles
US3732245A (en) * 1970-11-04 1973-05-08 Hoffmann La Roche Process and intermediates for the preparation of indoles from ortho-nitrotoluenes
US3979410A (en) * 1974-01-21 1976-09-07 Hoffmann-La Roche Inc. Intermediate α-acyl-β-dialkylamino-2-nitrostyrenes
US4137404A (en) * 1977-12-20 1979-01-30 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4665087A (en) * 1982-02-22 1987-05-12 Ciba-Geigy Corporation 1-(carbamyl, thiocarbamyl, and iminocarbamyl)-indoline derivatives
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process

Also Published As

Publication number Publication date
FI915735A (fi) 1992-06-06
EP0489547B1 (en) 1998-07-29
FI915735A0 (fi) 1991-12-05
CS363391A3 (en) 1992-06-17
KR100228328B1 (ko) 1999-11-01
IL100055A (en) 1996-12-05
NO914775L (no) 1992-06-09
CA2056065A1 (en) 1992-06-06
ZA919079B (en) 1992-09-30
HU913759D0 (en) 1992-02-28
SK278987B6 (sk) 1998-05-06
DE69129894T2 (de) 1998-12-10
PT99683A (pt) 1992-10-30
JP3160040B2 (ja) 2001-04-23
PT99683B (pt) 1999-05-31
AU652002B2 (en) 1994-08-11
NO175680B (no) 1994-08-08
JPH04266870A (ja) 1992-09-22
EP0489547A1 (en) 1992-06-10
FI102170B (fi) 1998-10-30
NO175680C (no) 1994-11-16
ATE168998T1 (de) 1998-08-15
HU222123B1 (hu) 2003-04-28
CA2056065C (en) 2003-07-29
NO914775D0 (no) 1991-12-04
FI102170B1 (fi) 1998-10-30
CZ282019B6 (cs) 1997-04-16
US5280125A (en) 1994-01-18
DE69129894D1 (de) 1998-09-03
DK0489547T3 (da) 1999-04-26
RU2054417C1 (ru) 1996-02-20
AU8794691A (en) 1992-06-11
IE913936A1 (en) 1992-06-17
GB9026427D0 (en) 1991-01-23
HUT60716A (en) 1992-10-28
NZ240624A (en) 1994-01-26
IL100055A0 (en) 1992-08-18
ES2118743T3 (es) 1998-10-01

Similar Documents

Publication Publication Date Title
Anthony Novel synthesis of heterocyclic ketones
GB1359264A (en) Phenoxy-alkyl-carboxylic acid derivatives ant the preparation thereof
HU222577B1 (hu) 1-(2,4-Diklór-fenil)-5-(4-klór-fenil)-3-pirazolkarbonsav-származék intermedierek pirazolszármazékok előállításához
US4334073A (en) Process for the preparation of alpha-hydroxycarboxylic acid amide compounds
HUP9904608A2 (hu) Eljárás N-(amino-4,6-dihalogén-pirimidin)-formamidok előállítására
Senda et al. Pyrimidine derivatives and related compounds. 15. Synthesis and analgetic and antiinflammatory activities of 1, 3-substituted 5-amino-6-methyluracil derivatives
ES8708142A1 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
CA2016501C (en) Substituted pyrrole compounds and their applications in pharmacy
AP1519A (en) Process for the preparation of thiazolidinedione derivatives.
KR920012029A (ko) 3위치에 치환된 인돌(indole)의 신규의 제조방법 및 본 방법에서 유용한 중간체
CA1135699A (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their production and their medicinal use
US4435417A (en) Antiinflammatory 3H-naphtho[1,2-d]imidazoles
GB1368256A (en) 1- trifluoromethyl-phenyl- 4-cyclic-amidoalkyl- piperazines useful as amorectic agents
EP0348257A2 (fr) Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique
EG17902A (en) N-alkylation of dihydrolysergic acid
US4125717A (en) Process for the preparation of oxazine dyestuffs
US4200759A (en) Preparation of imidazo[2,1-a]isoindole compounds
US2999110A (en) 1-(substituted phenyl alkanoyl)-3-alkoxy ureas
Salerno et al. Synthesis of Substituted 1 H, 5-Dihydroimidazolium Salts by Dehydrogenation of Imidazolidines
GB1576841A (en) Substituted n-acyl phenylamine compounds having hypolipidaemic activity
US5001228A (en) Bis-alkylamide azo polymerization initiators
US2762805A (en) 3-ethyl-3-phenyl-2, 6-piperazinedione and derivatives thereof
GB1144454A (en) Acylated indolylmethyl tetrazoles and a process for the preparation thereof
GB1504151A (en) Methods using and compositions containing quinone derivatives for use in animal husbandry
US4614830A (en) Esterification process

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040714

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee